OCEANSIDE, Calif.--(BUSINESS WIRE)--International Stem Cell (OTCBB:ISCO), www.internationalstemcell.com, announced today that Dr. Alan Copperman, M.D. has joined the company’s Scientific Advisory Board.
International Stem Cell Corporation, “ISCO” is a California company that has developed, for the first time under controlled conditions, human stem cell lines that promise to eliminate the rejection of transplanted cells by the patient’s immune system. ISCO’s technology, called parthenogenesis, results in the creation of pluripotent human stem cell lines (called phESC) from unfertilized human eggs. This new methodology offers the potential to create the first “Stem Cell Bank” with the capacity to provide rejection-resistant stem cells that can become any cell in the human body, and also addresses critical ethical issues by eliminating the need to use fertilized embryos. ISCO also produces and sells the Lifeline brand of specialized cells and growth media worldwide for therapeutic research.
